Sanjay B. Hari, Ethan A. Merritt, Dustin J. Maly  Chemistry & Biology 

Slides:



Advertisements
Similar presentations
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Advertisements

Volume 18, Issue 2, Pages (February 2010)
Structural Basis for the Highly Selective Inhibition of MMP-13
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 21, Issue 4, Pages (April 2014)
Volume 23, Issue 4, Pages (April 2015)
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
Crystal Structures of Sirt3 Complexes with 4′-Bromo-Resveratrol Reveal Binding Sites and Inhibition Mechanism  Giang Thi Tuyet Nguyen, Melanie Gertz,
Structure of an LDLR-RAP Complex Reveals a General Mode for Ligand Recognition by Lipoprotein Receptors  Carl Fisher, Natalia Beglova, Stephen C. Blacklow 
Volume 17, Issue 12, Pages (December 2009)
Volume 22, Issue 9, Pages (September 2014)
MAP Kinase-Interacting Kinases—Emerging Targets against Cancer
Volume 24, Issue 12, Pages (December 2016)
Volume 24, Issue 8, Pages (August 2016)
Volume 125, Issue 4, Pages (May 2006)
Volume 36, Issue 4, Pages (November 2009)
Volume 14, Issue 5, Pages (May 2007)
Volume 18, Issue 11, Pages (November 2010)
Crystal Structure of the Rab9A-RUTBC2 RBD Complex Reveals the Molecular Basis for the Binding Specificity of Rab9A with RUTBC2  Zhe Zhang, Shanshan Wang,
Volume 21, Issue 2, Pages (February 2013)
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Choel Kim, Cecilia Y. Cheng, S. Adrian Saldanha, Susan S. Taylor  Cell 
Volume 19, Issue 5, Pages (May 2011)
Structure-Guided Design of Fluorescent S-Adenosylmethionine Analogs for a High- Throughput Screen to Target SAM-I Riboswitch RNAs  Scott F. Hickey, Ming C.
Volume 21, Issue 5, Pages (May 2014)
Volume 26, Issue 1, Pages e5 (January 2019)
Riboswitches: Fold and Function
Ins and Outs of Kinase DFG Motifs
Volume 22, Issue 9, Pages (September 2014)
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
A Conformational Switch in the CRIB-PDZ Module of Par-6
Mechanism of Sirtuin Inhibition by Nicotinamide: Altering the NAD+ Cosubstrate Specificity of a Sir2 Enzyme  José L. Avalos, Katherine M. Bever, Cynthia.
Volume 20, Issue 10, Pages (October 2012)
Volume 19, Issue 8, Pages (August 2012)
Structural Basis for Protein Recognition by B30.2/SPRY Domains
A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors
Volume 15, Issue 9, Pages (September 2008)
Sachin Surade, Tom L. Blundell  Chemistry & Biology 
Jiao Yang, Melesse Nune, Yinong Zong, Lei Zhou, Qinglian Liu  Structure 
Volume 12, Issue 11, Pages (November 2005)
Volume 26, Issue 1, Pages (April 2007)
Volume 20, Issue 2, Pages (February 2013)
Structural Basis for the Highly Selective Inhibition of MMP-13
Volume 22, Issue 1, Pages (January 2014)
Volume 15, Issue 2, Pages (February 2007)
A General Framework for Inhibitor Resistance in Protein Kinases
Volume 23, Issue 6, Pages (June 2015)
Tianjun Zhou, Liguang Sun, John Humphreys, Elizabeth J. Goldsmith 
Volume 21, Issue 2, Pages (February 2013)
Volume 6, Issue 4, Pages (October 2000)
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases  Sanjay B.
Volume 52, Issue 3, Pages (November 2013)
The Active Conformation of the PAK1 Kinase Domain
Volume 12, Issue 1, Pages (July 2015)
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Ethan B. Butler, Yong Xiong, Jimin Wang, Scott A. Strobel 
Volume 21, Issue 10, Pages (October 2014)
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
The Structure of JNK3 in Complex with Small Molecule Inhibitors
Volume 20, Issue 1, Pages (January 2012)
Structural Basis of RIP1 Inhibition by Necrostatins
Guilty as charged Cancer Cell
Activation of Pheromone-Sensitive Neurons Is Mediated by Conformational Activation of Pheromone-Binding Protein  John D. Laughlin, Tal Soo Ha, David N.M.
Insights from Free-Energy Calculations: Protein Conformational Equilibrium, Driving Forces, and Ligand-Binding Modes  Yu-ming M. Huang, Wei Chen, Michael J.
A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors
Volume 7, Issue 2, Pages R19-R23 (February 1999)
Volume 18, Issue 11, Pages (November 2010)
Peter Man-Un Ung, Rayees Rahman, Avner Schlessinger 
Volume 25, Issue 4, Pages e4 (April 2018)
Volume 21, Issue 6, Pages (June 2013)
Presentation transcript:

Sequence Determinants of a Specific Inactive Protein Kinase Conformation  Sanjay B. Hari, Ethan A. Merritt, Dustin J. Maly  Chemistry & Biology  Volume 20, Issue 6, Pages 806-815 (June 2013) DOI: 10.1016/j.chembiol.2013.05.005 Copyright © 2013 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2013 20, 806-815DOI: (10. 1016/j. chembiol. 2013 Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 1 A Probe for Type II Ligand Sensitivity (A) General properties of a type II ligand, which spans a kinase active site from beyond the adenosine pocket through a hydrophobic pocket that would otherwise be occupied by the DFG motif phenylalanine. (B) Structure of probe F. (C) Titration of MAPKs in the presence of probe F shows the most change in fluorescence for p38α (blue triangles; Kd = 15 nM). Error bars indicate ± SEM for three replicates. (D) Active site dissociation of probe F from p38α. The slow dissociation rate (t1/2 = 80 min) is indicative of the large conformational change required to accommodate a type II inhibitor. (E) The hydrophobic spines of protein kinase A (C-spine, yellow; N-spine, blue), connected by the gatekeeper (cyan) and xDFG (green) residues (Protein Data Bank [PDB] 1ATP). (F) Sequence alignments of MAPK hydrophobic spines shows that most of the residues are conserved within the MAPK family. The gatekeeper (cyan boxed) and xDFG (green boxed) residues are the only positions with significant variability. (G) Active site dissociation of probe F from MAPKs. A gatekeeper/xDFG double mutant of Erk2 (Q103T/C164L, black squares) dissociates from probe F at a similar rate to p38α (blue triangles). See also Figure S1. Chemistry & Biology 2013 20, 806-815DOI: (10.1016/j.chembiol.2013.05.005) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 2 Structures of L1–L4 and Probe F Despite varied structures, all of these inhibitors stabilize the DFG-out inactive conformation. Polar contacts are shown with dashed lines. Chemistry & Biology 2013 20, 806-815DOI: (10.1016/j.chembiol.2013.05.005) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 3 L2-Bound Erk2 Q103A/C164L Adopts the DFG-Out Inactive Conformation (A) Erk2 Q103A/C164L with L2 (cyan) and Phe-166 (salmon) contoured at 1.0 σ. Part of the N-lobe beta sheet is hidden for clarity. (B) Interaction map of L2 in the active site of Erk2 Q103A/C164L. Map generated by LigPlot+ (Laskowski and Swindells, 2011). (C) Superimposition of L2-bound Erk2 Q103A/C164L (green) with apo inactive Erk2 (orange; activation loop shown only) (PDB 1ERK) reveals a large activation loop translocation. (D) Superimposition of L2-bound Erk2 Q103A/C164L (green) with L4-bound p38α (magenta; activation loop shown only) (PDB 2BAJ). No pi-stacking is observed between Phe-169 and Tyr-182 in p38α. See also Table S1. Chemistry & Biology 2013 20, 806-815DOI: (10.1016/j.chembiol.2013.05.005) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 4 ICAT Footprinting of Inhibitor-Sensitive and Inhibitor-Insensitive Erk2 (A) Residue positions studied (black sticks). The hinge region (yellow), activation loop (cyan), DFG motif (magenta sticks), and gatekeeper residue (spheres) are also shown (PDB 1ERK). (B) Footprinting time courses. The proximity of position 82 to the gatekeeper provides the explanation that a smaller gatekeeper residue, as in the case of Erk2 Q103T/C164L, would provide greater solvent accessibility and a faster alkylation rate. Position 172, however, is far from the gatekeeper and still shows altered rates for both Erk Q103T/C164L and Q103A/C164L. Error bars indicate ± SEM for three replicates. See also Figures S2 and S3. Chemistry & Biology 2013 20, 806-815DOI: (10.1016/j.chembiol.2013.05.005) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 5 The Gatekeeper/xDFG Sensitization Strategy Is General (A) Kinome dendrogram with the S/T kinases p38α (black) and Stk10 (red) circled illustrates the distant relationship between the two kinases. Kinome illustration reproduced courtesy of Cell Signaling Technology (http://www.cellsignal.com). (B) Stk10 bound to L3 (magenta) in the DFG-out conformation with activation loop (yellow; F176 in sticks) highlighted (PDB 4EQU). (C) Inhibition data of STE group kinases against inhibitors L1–L4 and binding and dissociation data of probe F. The ASK1 gatekeeper/xDFG double mutant (M754T/S821C) is inhibited at nanomolar levels for all inhibitors tested and binds to probe F with nanomolar affinity. n/d, not determined. Chemistry & Biology 2013 20, 806-815DOI: (10.1016/j.chembiol.2013.05.005) Copyright © 2013 Elsevier Ltd Terms and Conditions